{
  "nctId": "NCT03223272",
  "briefTitle": "Mechanisms of Refractory Hypertension (Reserpine)",
  "officialTitle": "Mechanisms of Refractory Hypertension (Reserpine)",
  "protocolDocument": {
    "nctId": "NCT03223272",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-11-02",
    "uploadDate": "2021-11-02T09:43",
    "size": 416028,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03223272/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE2"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 7,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-07-23",
    "completionDate": "2020-01-31",
    "primaryCompletionDate": "2020-01-31",
    "firstSubmitDate": "2017-07-17",
    "firstPostDate": "2017-07-21"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n\\- adult with refractory hypertension defined as uncontrolled office blood pressure with use of 5 or more hypertensive agents, including a thiazide diuretic and spironolactone\n\nExclusion Criteria:\n\n* congestive heart failure (EF 40%)\n* chronic kidney disease (GFR \\<40 ml/min/1.73 mm)\n* stroke and/or myocardial infarction or acute CHF exacerbation within last 3 months\n* ongoing depression\n* active peptic ulcer disease\n* bradycardia \\<50 beats per minute\n* 2nd or 3rd degree heart block\n* known intolerance of reserpine\n* use of digoxin or tricycle antidepressants",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "19 Years",
    "maximumAge": "80 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change Ambulatory Systolic Blood Pressure",
        "description": "Twenty-four hour ambulatory systolic blood pressure",
        "timeFrame": "Baseline and 8 weeks"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [
        "PHASE2"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 14,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:29:13.790Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}